Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 769 to 773 of 773 entries
Sorted by: Best Match Show Resources per page
Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring.

Journal of endocrinological investigation

Longo M, Scappaticcio L, Petrizzo M, Castaldo F, Sarnataro A, Forestiere D, Caiazzo F, Bellastella G, Maiorino MI, Capuano A, Esposito K.
PMID: 34482534
J Endocrinol Invest. 2021 Sep 05; doi: 10.1007/s40618-021-01669-3. Epub 2021 Sep 05.

PURPOSE: This study is aimed at evaluating changes in metrics of glucose control in home-isolated patients with type 1 diabetes and COVID-19 using a continuous glucose monitoring (CGM) system.METHODS: We included adults aged 18-45 years with type 1 diabetes,...

Cite
Longo M, Scappaticcio L, Petrizzo M, et al. Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring. J Endocrinol Invest. 2021;doi: 10.1007/s40618-021-01669-3.
Longo, M., Scappaticcio, L., Petrizzo, M., Castaldo, F., Sarnataro, A., Forestiere, D., Caiazzo, F., Bellastella, G., Maiorino, M. I., Capuano, A., & Esposito, K. (2021). Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring. Journal of endocrinological investigation, . https://doi.org/10.1007/s40618-021-01669-3
Longo, M, et al. "Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring." Journal of endocrinological investigation vol. (2021). doi: https://doi.org/10.1007/s40618-021-01669-3
Longo M, Scappaticcio L, Petrizzo M, Castaldo F, Sarnataro A, Forestiere D, Caiazzo F, Bellastella G, Maiorino MI, Capuano A, Esposito K. Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring. J Endocrinol Invest. 2021 Sep 05; doi: 10.1007/s40618-021-01669-3. Epub 2021 Sep 05. PMID: 34482534; PMCID: PMC8418789.
Copy Download .nbib Format: NLM
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives.

Pharmacological research

Cucchiara F, Petrini I, Romei C, Crucitta S, Lucchesi M, Valleggi S, Scavone C, Capuano A, De Liperi A, Chella A, Danesi R, Del Re M.
PMID: 33940185
Pharmacol Res. 2021 Jul;169:105643. doi: 10.1016/j.phrs.2021.105643. Epub 2021 Apr 30.

Lung cancer has become a paradigm for precision medicine in oncology, and liquid biopsy (LB) together with radiomics may have a great potential in this scenario. They are both minimally invasive, easy to perform, and can be repeated during...

Cite
Cucchiara F, Petrini I, Romei C, et al. Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives. Pharmacol Res. 2021;169:105643doi: 10.1016/j.phrs.2021.105643.
Cucchiara, F., Petrini, I., Romei, C., Crucitta, S., Lucchesi, M., Valleggi, S., Scavone, C., Capuano, A., De Liperi, A., Chella, A., Danesi, R., & Del Re, M. (2021). Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives. Pharmacological research, 169105643. https://doi.org/10.1016/j.phrs.2021.105643
Cucchiara, Federico, et al. "Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives." Pharmacological research vol. 169 (2021): 105643. doi: https://doi.org/10.1016/j.phrs.2021.105643
Cucchiara F, Petrini I, Romei C, Crucitta S, Lucchesi M, Valleggi S, Scavone C, Capuano A, De Liperi A, Chella A, Danesi R, Del Re M. Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives. Pharmacol Res. 2021 Jul;169:105643. doi: 10.1016/j.phrs.2021.105643. Epub 2021 Apr 30. PMID: 33940185.
Copy Download .nbib Format: NLM
Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection.

Frontiers in oncology

Grammatica A, Piazza C, Ferrari M, Verzeletti V, Paderno A, Mattavelli D, Schreiber A, Lombardi D, Fazio E, Gazzini L, Giorgetti G, Buffoli B, Rodella LF, Nicolai P, Calabrese L.
PMID: 33968719
Front Oncol. 2021 Apr 23;11:613945. doi: 10.3389/fonc.2021.613945. eCollection 2021.

BACKGROUND: The aim of oral cancer surgery is tumor removal within clear margins of healthy tissue: the latter definition in the literature, however, may vary between 1 and 2 cm, and should be intended in the three dimensions, which...

Cite
Grammatica A, Piazza C, Ferrari M, et al. Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection. Front Oncol. 2021;11:613945doi: 10.3389/fonc.2021.613945.
Grammatica, A., Piazza, C., Ferrari, M., Verzeletti, V., Paderno, A., Mattavelli, D., Schreiber, A., Lombardi, D., Fazio, E., Gazzini, L., Giorgetti, G., Buffoli, B., Rodella, L. F., Nicolai, P., & Calabrese, L. (2021). Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection. Frontiers in oncology, 11613945. https://doi.org/10.3389/fonc.2021.613945
Grammatica, Alberto, et al. "Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection." Frontiers in oncology vol. 11 (2021): 613945. doi: https://doi.org/10.3389/fonc.2021.613945
Grammatica A, Piazza C, Ferrari M, Verzeletti V, Paderno A, Mattavelli D, Schreiber A, Lombardi D, Fazio E, Gazzini L, Giorgetti G, Buffoli B, Rodella LF, Nicolai P, Calabrese L. Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection. Front Oncol. 2021 Apr 23;11:613945. doi: 10.3389/fonc.2021.613945. eCollection 2021. PMID: 33968719; PMCID: PMC8104033.
Copy Download .nbib Format: NLM
Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project.

Pharmaceuticals (Basel, Switzerland)

Maniscalco GT, Brescia Morra V, Florio C, Lus G, Tedeschi G, Cianfrani M, Docimo R, Miniello S, Romano F, Sinisi L, Spitaleri DLA, Longo G, Trama U, Triassi M, Fasm Group, Scavone C, Capuano A.
PMID: 33333889
Pharmaceuticals (Basel). 2020 Dec 15;13(12). doi: 10.3390/ph13120466.

BACKGROUND AND AIM: Disease-modifying therapies (DMTs) used in multiple sclerosis (MS) have distinct safety profiles. In this paper, we report preliminary results of an on-going pharmacovigilance project (the FASM study).RESULTS: Neurologists working at involved multiple sclerosis centers collected 272...

Cite
Maniscalco GT, Brescia Morra V, Florio C, et al. Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project. Pharmaceuticals (Basel). 2020;13(12)doi: 10.3390/ph13120466.
Maniscalco, G. T., Brescia Morra, V., Florio, C., Lus, G., Tedeschi, G., Cianfrani, M., Docimo, R., Miniello, S., Romano, F., Sinisi, L., Spitaleri, D. L. A., Longo, G., Trama, U., Triassi, M., Fasm Group, Scavone, C., & Capuano, A. (2020). Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project. Pharmaceuticals (Basel, Switzerland), 13(12), . https://doi.org/10.3390/ph13120466
Maniscalco, Giorgia Teresa, et al. "Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project." Pharmaceuticals (Basel, Switzerland) vol. 13,12 (2020). doi: https://doi.org/10.3390/ph13120466
Maniscalco GT, Brescia Morra V, Florio C, Lus G, Tedeschi G, Cianfrani M, Docimo R, Miniello S, Romano F, Sinisi L, Spitaleri DLA, Longo G, Trama U, Triassi M, Fasm Group, Scavone C, Capuano A. Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project. Pharmaceuticals (Basel). 2020 Dec 15;13(12). doi: 10.3390/ph13120466. PMID: 33333889; PMCID: PMC7765255.
Copy Download .nbib Format: NLM
Lipopolysaccharide O-antigen molecular and supramolecular modifications of plant root microbiota are pivotal for host recognition.

Carbohydrate polymers

Vanacore A, Vitiello G, Wanke A, Cavasso D, Clifton LA, Mahdi L, Campanero-Rhodes MA, Solís D, Wuhrer M, Nicolardi S, Molinaro A, Marchetti R, Zuccaro A, Paduano L, Silipo A.
PMID: 34893256
Carbohydr Polym. 2022 Feb 01;277:118839. doi: 10.1016/j.carbpol.2021.118839. Epub 2021 Nov 08.

Lipopolysaccharides, the major outer membrane components of Gram-negative bacteria, are crucial actors of the host-microbial dialogue. They can contribute to the establishment of either symbiosis or bacterial virulence, depending on the bacterial lifestyle. Plant microbiota shows great complexity, promotes...

Cite
Vanacore A, Vitiello G, Wanke A, et al. Lipopolysaccharide O-antigen molecular and supramolecular modifications of plant root microbiota are pivotal for host recognition. Carbohydr Polym. 2021;277:118839doi: 10.1016/j.carbpol.2021.118839.
Vanacore, A., Vitiello, G., Wanke, A., Cavasso, D., Clifton, L. A., Mahdi, L., Campanero-Rhodes, M. A., Solís, D., Wuhrer, M., Nicolardi, S., Molinaro, A., Marchetti, R., Zuccaro, A., Paduano, L., & Silipo, A. (2022). Lipopolysaccharide O-antigen molecular and supramolecular modifications of plant root microbiota are pivotal for host recognition. Carbohydrate polymers, 277118839. https://doi.org/10.1016/j.carbpol.2021.118839
Vanacore, Adele, et al. "Lipopolysaccharide O-antigen molecular and supramolecular modifications of plant root microbiota are pivotal for host recognition." Carbohydrate polymers vol. 277 (2022): 118839. doi: https://doi.org/10.1016/j.carbpol.2021.118839
Vanacore A, Vitiello G, Wanke A, Cavasso D, Clifton LA, Mahdi L, Campanero-Rhodes MA, Solís D, Wuhrer M, Nicolardi S, Molinaro A, Marchetti R, Zuccaro A, Paduano L, Silipo A. Lipopolysaccharide O-antigen molecular and supramolecular modifications of plant root microbiota are pivotal for host recognition. Carbohydr Polym. 2022 Feb 01;277:118839. doi: 10.1016/j.carbpol.2021.118839. Epub 2021 Nov 08. PMID: 34893256.
Copy Download .nbib Format: NLM
Showing 769 to 773 of 773 entries